Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/08/2007WO2007125293A1 Mono and combination therapy with a m1/m4 muscarinic agonist (sabcomeline) for treatment of cognitive disorders in schizophrenia
11/08/2007WO2007125290A1 Mono and combination therapy of m1/m4 agonist (sabcomeline) for treatment of negative symptoms of schizophrenia
11/08/2007WO2007125287A1 Mono and combination therapy with m1/m4 muscarinic agonist (sabcomeline) for treatment of prodromal syndrome
11/08/2007WO2007125262A1 Use of a dermatological composition comprising a combination of hydroquinone, fluocinolone acetonide and tretinoin, for treating hyperpigmentation of pathological scars
11/08/2007WO2007125246A1 Use of a tricyclic compound for preparing a medicine for treating skeletal muscle degeneration
11/08/2007WO2007125245A1 Use of a compound inducing an increase of free serotonin rate in the body, for preparing a medicine for treating skeletal muscle degeneration
11/08/2007WO2007125243A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity
11/08/2007WO2007125203A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials.
11/08/2007WO2007125197A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007WO2007125196A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007WO2007125194A1 New gem-difluoro c-glycoside compounds derived from podophyllotoxin, preparation and uses thereof
11/08/2007WO2007125173A2 Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
11/08/2007WO2007125147A1 Isoprenaline, noradrenaline and adrenaline composition
11/08/2007WO2007125110A1 N- ( 2-thiazolyl) -amide derivatives as gsk-3 inhibitors
11/08/2007WO2007125109A1 N- (2-thiazolyl) -amide derivatives as gsk-3 inhibitors
11/08/2007WO2007125103A2 Benzamide glucokinase activators
11/08/2007WO2007125074A1 Use of alverine for the prevention and/or treatment of male and female sexual dysfunctions
11/08/2007WO2007125061A1 Spirocompounds useful as modulators for dopamine d3 receptors
11/08/2007WO2007125049A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators
11/08/2007WO2007125048A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators
11/08/2007WO2007124949A1 Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives
11/08/2007WO2007124903A1 Spirocyclic cyclohexane derivative with analgesic properties
11/08/2007WO2007124898A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
11/08/2007WO2007124869A2 Liquid pharmaceutical formulation
11/08/2007WO2007124854A1 Heterocyclic substituted, anellated pyrazole derivative and its uses
11/08/2007WO2007124849A2 Inhibitors of the task-1 and task-3 ion channel
11/08/2007WO2007124832A1 4-amino-2,6-dimethylphenol compound, process for its preparation and pharmaceutical composition comprising the same
11/08/2007WO2007124757A2 Use of escitalopram for improving cognition
11/08/2007WO2007124734A2 Compounds a-r-x for the manufacture of pharmaceutical preparations
11/08/2007WO2007124700A2 Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
11/08/2007WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin
11/08/2007WO2007124642A1 A pharmaceutical formulation for treating tinea of feet and hands and preparation thereof
11/08/2007WO2007124625A1 Limax polysaccharides, the production process and the use of the same
11/08/2007WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses
11/08/2007WO2007124598A2 Softgel capsules with phytosterols and/or phytostanols and optionlly omega polyunstaurated fatty acids
11/08/2007WO2007124597A1 Composition comprising one or more esterified phytosterols and/or phytostanols into which are solubilized one or more unesterified phytosterols and/or phytostanols, in order to achieve therapeutic and formulation benefits
11/08/2007WO2007124589A1 Methods for treating or preventing neoplasias
11/08/2007WO2007124546A1 Integrase inhibitors 3
11/08/2007WO2007124545A1 Integrase inhibitors - 2
11/08/2007WO2007124544A1 Integrase inhibitors - 1
11/08/2007WO2007109884A8 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent
11/08/2007WO2007109801A3 Extracts and methods comprising ganoderma species
11/08/2007WO2007109037A3 Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
11/08/2007WO2007104783A3 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators
11/08/2007WO2007104485A3 Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs
11/08/2007WO2007103970A3 Compositions and methods for treating respiratory disorders
11/08/2007WO2007103884A3 Compositions and methods for the treatment of multiple sclerosis
11/08/2007WO2007103584A3 Polyamides for treating human papilloma virus
11/08/2007WO2007103550A3 Substituted aminothiazole derivatives with anti-hcv activity
11/08/2007WO2007103427A3 Medical use of bilirubin and its structural analogues
11/08/2007WO2007097720A3 Method and reagents for treating hepatic fibrosis and inflammation
11/08/2007WO2007096931A3 Use of piperacillin in topical intravaginal preparations for the treatment of vaginal bacterial infections
11/08/2007WO2007096733A3 Desloratadine-containing formulation stabilized with cyclodextrin
11/08/2007WO2007096601A3 Antimicrobial formulations comprising a quinone and a copper salt
11/08/2007WO2007096164A3 Creatine for the treatment of l-dopa-induced dyskinesias
11/08/2007WO2007095602A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
11/08/2007WO2007092854A3 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
11/08/2007WO2007092590A3 Anti-mycobacterial formulation comprising octanesulphonylacetamide (osa), nonanesulphonylacetamide (nsa) and decanesulphonylacetamide (dsa)
11/08/2007WO2007092329A3 Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders
11/08/2007WO2007092095A3 [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
11/08/2007WO2007090822A3 Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
11/08/2007WO2007090134A3 Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma
11/08/2007WO2007089557A3 Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators
11/08/2007WO2007087441A3 Substituted aromatic compounds for inflammation and immune-related uses
11/08/2007WO2007087395A3 UNSATURATED mTOR INHIBITORS
11/08/2007WO2007086895A9 Antibacterial compounds and uses thereof
11/08/2007WO2007084868A3 Treatment of disorders by activation of the unfolded protein response
11/08/2007WO2007084661A3 Therapy-enhancing glucan
11/08/2007WO2007084548A3 Viral treatment
11/08/2007WO2007084435A3 Methods for treating hepatitis c
11/08/2007WO2007084331A3 Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
11/08/2007WO2007084157A3 Nucleoside prodrugs for treating viral infections
11/08/2007WO2007082262A3 Novel compounds
11/08/2007WO2007082052A3 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
11/08/2007WO2007081857A3 Cycloalkylamines as monoamine reuptake inhibitors
11/08/2007WO2007081744A3 Methods and compositions for administration of iron
11/08/2007WO2007081729A3 Treatment modalities for autoimmune diseases
11/08/2007WO2007081583A3 Anti-pneumococcal preparations and methods of use
11/08/2007WO2007079177A3 Novel phytic citrate compounds and process for preparing the same
11/08/2007WO2007079171A3 Treatment for hodgkin's lymphoma
11/08/2007WO2007079119A3 Process for manufacturing picolinate borinic esters
11/08/2007WO2007076087A3 3-aryl-substituted quinazolones, and uses thereof
11/08/2007WO2007074915A8 Water-soluble benzoazepine compound and its pharmaceutical composition
11/08/2007WO2007074406A3 Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
11/08/2007WO2007072221A3 Surface marker-directed cancer therapeutics
11/08/2007WO2007071752A3 Pyrimidinyl aryl urea derivatives being fgf inhibitors
11/08/2007WO2007071357A3 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid
11/08/2007WO2007070834A3 Controlling toxicity of aminoquinoline compounds
11/08/2007WO2007070598A9 Nucleotide and oligonucleotide prodrugs
11/08/2007WO2007070568A3 Demethylpenclomedine analogs and their use as anticancer agents
11/08/2007WO2007069073A3 Pharmaceutical formulations of amyloid inhibiting compounds
11/08/2007WO2007067875A3 Pyridinyl sulfonamide modulators of chemokine receptors
11/08/2007WO2007067504A3 Lactam compounds and methods of using the same
11/08/2007WO2007062877A3 PRODRUG ERβ-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
11/08/2007WO2007062403A3 Compositions useful for reducing nephrotoxicity and methods of use thereof
11/08/2007WO2007062381A3 Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis
11/08/2007WO2007062334A3 New pleuromutilin derivative and its use
11/08/2007WO2007062333A3 New pleuromutilin derivative and its use
11/08/2007WO2007062324A3 Hair restorative compositions and methods for cosmetically treating damaged hair
11/08/2007WO2007062076A3 Dexrazoxane formulations and methods
1 ... 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 ... 7860